Please use this identifier to cite or link to this item:
Scopus Web of ScienceĀ® Altmetric
Type: Journal article
Title: Analysis of families with Lynch syndrome complicated by advanced serrated neoplasia: the importance of pathology review and pedigree analysis
Author: Walsh, M.
Buchanan, D.
Walters, R.
Roberts, A.
Arnold, S.
McKeone, D.
Clendenning, M.
Ruszkiewicz, A.
Jenkins, M.
Hopper, J.
Goldblatt, J.
George, J.
Suthers, G.
Phillips, K.
Young, G.
Macrae, F.
Drini, M.
Woods, M.
Parry, S.
Jass, J.
et al.
Citation: Familial Cancer, 2009; 8(4):313-323
Publisher: Kluwer Acadmic Publishers Group
Issue Date: 2009
ISSN: 1389-9600
Statement of
Michael D. Walsh... Andrew R. Ruszkiewicz... Jack Goldblatt... Graeme K. Suthers... et al.
Abstract: The identification of Lynch syndrome has been greatly assisted by the advent of tumour immunohistochemistry (IHC) for mismatch repair (MMR) proteins, and by the recognition of the role of acquired somatic BRAF mutation in sporadic MMR-deficient colorectal cancer (CRC). However, somatic BRAF mutation may also be present in the tumours in families with a predisposition to develop serrated polyps in the colorectum. In a subgroup of affected members in these families, CRCs emerge which demonstrate clear evidence of MMR deficiency with absent MLH1 staining and high-level microsatellite instability (MSI). This may result in these families being erroneously classified as Lynch syndrome, or conversely, an individual is considered "sporadic" due to the presence of a somatic BRAF mutation in a tumour. In this report, we describe two Lynch syndrome families who demonstrated several such inconsistencies. In one family, IHC deficiency of both MSH2 and MLH1 was demonstrated in tumours from different affected family members, presenting a confusing diagnostic picture. In the second family, MLH1 loss was observed in the lesions of both MLH1 mutation carriers and those who showed normal MLH1 germline sequence. Both families had Lynch syndrome complicated by an independently segregating serrated neoplasia phenotype, suggesting that in families such as these, tumour and germline studies of several key members, rather than of a single proband, are indicated to clarify the spectrum of risk.
Keywords: Lynch syndrome
BRAF mutation
Advanced serrated polyps
DOI: 10.1007/s10689-009-9238-8
Published version:
Appears in Collections:Aurora harvest 5
Paediatrics publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.